Efficacy of alteplase 1 vs 2 mg dose in restoring haemodialysis catheter function (Alte-dose 2): A randomized double-blind controlled study
Nephrology Feb 02, 2020
El-Masri MM, et al. - By performing this double-blind, randomized, controlled clinical trial, researchers compared alteplase 2 mg vs 1 mg in terms of effectiveness in restoring haemodialysis catheter occlusion (HDC) function. This inquiry was carried out at a single-centre in southwestern Ontario, Canada. They used Kaplan–Meier, Cox-proportional hazard and clustered logic regression analyses to determine the rate of clot resolution, catheter replacements, catheter stripping, and mean catheter survival time. This analysis included 48 haemodialysis patients who afforded 252 catheter occlusion events. In the 2 mg group vs in the 1 mg group, the rate of clot resolution at the catheter site was estimated to be 85.7% vs 84.9%, respectively. Just six catheter removals and 10 catheter stripping events were reported. Findings revealed the equivalent effectiveness of alteplase 1 mg vs alteplase 2 mg in restoring HDC malfunction. In addition, alteplase 1 mg may lead to a cost reduction in haemodialysis units.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries